scPharmaceuticals Announces Furoscix NDA Resubmission
BURLINGTON, Mass.--(BUSINESS WIRE)--Jul. 1, 2020-- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news
More News: Drugs & Pharmacology | New Drug Applications